Aiming for the outliers: Cancer precision medicine through targeting kinases with extreme expression

Research output: Contribution to journalArticlepeer-review

Abstract

With the increasing availability of highly potent, pharmacologically active, and selective protein kinase inhibitors, identification of individuals who would benefit from targeted kinase inhibitors could facilitate application of precision medicine strategies for cancer therapy. A recent study by Kothari and colleagues reports preclinical studies that highlight the potential of targeting kinases with extreme expression for cancer precision medicine, warranting further clinical investigation of an individual-specific outlier kinase targeting approach.

Original languageEnglish (US)
Pages (from-to)252-254
Number of pages3
JournalCancer discovery
Volume3
Issue number3
DOIs
StatePublished - Mar 2013

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Aiming for the outliers: Cancer precision medicine through targeting kinases with extreme expression'. Together they form a unique fingerprint.

Cite this